MYH9	myosin heavy chain 9
NM IIA	non-myosin heavy chain IIA
CB	Cinobufotalin
DT-13	saponin monomer 13
NMMHC IIA	non-muscle myosin heavy chain IIA
ROCK1	Rho-kinase 1
RLC	Rho light chain
NM II	non-myosin II
EMT	epithelial-mesenchymal transition
Pi	Phosphoric acid
MNA	May-Hegglin anomaly
EPS	Epstein syndrome
FTNS	Fechtner syndrome
SBS	Sebastian syndrome
HCC	hepatocellular carcinoma
AML	acute myeloid leukemia
EC	esophageal cancer
ccRCC	clear cell renal cell carcinoma
CRC	colorectal cancer
AAV9	adeno-associated virus serotype 9
GC	gastric cancer
PDAC	pancreatic ductal adenocarcinoma
NSCLC	non-small cell lung cancer
TUBB4A	tubulin beta class IVa
ATG9B	autophagy-associated protein 9B
LDs	lipid droplets
TGs	triglycerides
CSCC	cervical squamous cell carcinoma
HNSCC	head and neck squamous cell carcinoma
wtp 53	wild-type p53
EBP50	ezrin-radixin-moesin-binding phosphor protein 50
Me-EBP50	membrane EBP 50
ctDNA	circulating tumor DNA
HIF1α	hypoxia-inducible factor 1-alpha
TPT	topotecan
EGFR	epidermal growth factor receptor
HK II	hexokinase II
TME	tumor microenvironment
FGL 1	fibrinogen-like protein 1
MSS	microsatellite-stable
CTLs	cytotoxic T lymphocytes
LUAD	lung adenocarcinoma
TRCs	tumor regenerating cells
THBS 1	apatinib targets platelet-responsive protein 1
ITE	methyl 2-(1H-indole-3-carbonyl)-thiazole-4-carboxylate
AHR	aromatic hydrocarbon receptors
EC	esophagus cancer